SMAD7 and hepatocellular carcinoma: However, evidence suggests that HCC have acquired a resistance to TGFβ inhibition of proliferation through mechanisms that include decreased TGFβ-receptor II expression [12] or induction of the inhibitory SMAD7 in advanced HCC [12,13].